about
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to s...
Read More
15.07
-0.84
(-5.28%)
992.3K
XNAS Volume
XNAS 14 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Vor Biopharma Inc is on 22 May 2026 for the purpose of Vor Biopharma Inc Annual General Meeting for 2026
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Vor Biopharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..